跳至主要内容
临床试验/CTRI/2023/02/049386
CTRI/2023/02/049386尚未招募3 期

Evaluating the role of individualised homoeopathic remedy selected from the compiled repertory in case of pathological leucorrhoea : An open label prospective Quasi experimental study

Dr Dimple Kumari1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年1月2日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
2.To evaluate change in the quality of life in Leucorrhea patients by homoeopathic medicines.

研究概览

简要总结

This study is the Non Randomized, single blind open label prospective Quasi experimental study to see the results of the complied repertory in the treatment of pathological leucorrhea using Vaginal assessment form and ORIDL score. The duration of treatment will be 3 months and will be done on 50 patients at Bharati Vidyapeeth Medical Foundation Homoeopathic Hospital, peripheral O.P.D,various rural and urban camp series,O.P.D,I.P.D. The primary outcome will be assessed using the follow up taken for 3 months to see the effectiveness of homoeopathic medicines in the treatment of Pathological Leucorrhea. To see whether compiled repertory is useful in clinical prescribing of final similimum. The secondary outcome will measure the improvement in symptoms of patients using vaginal assessment form and ORIDL score at day 1 and 3rd month.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
Female

入选标准

  • 1 Patient attending OPD who is suffering from Leucorrhoea which is defined will be included for the study.
  • 2 Married Women irrespective of their religious and socio-economic status.
  • 3 Patient who are willing to take part in the study.

排除标准

  • 1 Patient taking oral contraceptives pills.
  • 2 Patient having defined life-threatening pathology in genital tract.
  • 3 Patient with Malignancy cases.
  • 4 Pregnant women and lactating mothers.

结局指标

主要结局

2.To evaluate change in the quality of life in Leucorrhea patients by homoeopathic medicines.

时间窗: the follow ups taken at every 15 days will be assessed for duration of 3 months using vaginal assessment form and ORIDL score at the beginning and end of treatment i.e. after 12 weeks and most prescribed homoeopathic medicine using complied repertory will be evaluated.

3.To determine the utility of compiled repertory for individualized homoeopathic treatment of pathological Leucorrhea.

时间窗: the follow ups taken at every 15 days will be assessed for duration of 3 months using vaginal assessment form and ORIDL score at the beginning and end of treatment i.e. after 12 weeks and most prescribed homoeopathic medicine using complied repertory will be evaluated.

1.To enlist the most frequently prescribed medicine for pathological Leucorrhea with their indication.

时间窗: the follow ups taken at every 15 days will be assessed for duration of 3 months using vaginal assessment form and ORIDL score at the beginning and end of treatment i.e. after 12 weeks and most prescribed homoeopathic medicine using complied repertory will be evaluated.

次要结局

  • To compile a Leucorrhea based repertory from all well-known established repertories.(To evaluate change in the quality of life in Leucorrhea patients by homoeopathic medicines.)

研究者

发起方
Dr Dimple Kumari
申办方类型
Other [self ]

研究点 (1)

Loading locations...

相似试验